• To global navigation
  • To contents

Mitsubishi Tanabe Pharma

  • HOME
  • JAPANESE TOP
  • Site Map
  • Contact Us

Mitsubishi Chemical Holdings Group

Print

  • Corporate Information
    • Message From The Management
    • Philosophy and Vision,Corporate Behavior Charter
    • Quality Policy
    • Compliance
    • Medium-Term Management Plan
    • Corporate Data
    • Management
    • Organization Chart
    • Network
    • Group Companies
    • Brand Mark
    • Corporate History
    • CSR Report
  • Research&Development
    • Developing Innovative New Drugs
    • R&D Pipeline
    • Clinical Trial Information
    • Research Reagent
  • Investor Relations
    • IR Top
    • Shareholder's Meeting
    • Financial Results
    • Financial Data
    • IR Meeting
    • Annual Report
    • IR Library
    • FAQ
    • IR Calendar
    • IR Inquiries
    • Cautionary Note
  • News Release
    • News Release
    • Topics

Japanese site

HOME>Research&Development>R&D Pipeline

R&D Pipeline

State of New Product Developmentpdf(As of May 8, 2013)


Research&Development

  • Developing Innovative New Drugs
  • R&D Pipeline
  • Clinical Trial Information
  • Research Reagent
  • Contact Us
  • Terms Of Use
  • Privacy Policy

Top of Page

© Mitsubishi Tanabe Pharma Corporation.